BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 21995569)

  • 1. NK cells: immune cross-talk and therapeutic implications.
    Malhotra A; Shanker A
    Immunotherapy; 2011 Oct; 3(10):1143-66. PubMed ID: 21995569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.
    Newman KC; Riley EM
    Nat Rev Immunol; 2007 Apr; 7(4):279-91. PubMed ID: 17380157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
    Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
    Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction during activation and inhibition of natural killer cells.
    Watzl C; Long EO
    Curr Protoc Immunol; 2010 Aug; Chapter 11():Unit 11.9B. PubMed ID: 20814939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy.
    Michen S; Temme A
    Crit Rev Immunol; 2016; 36(4):329-347. PubMed ID: 28322137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NK cells: From development to effector functions.
    Perera Molligoda Arachchige AS
    Innate Immun; 2021 Apr; 27(3):212-229. PubMed ID: 33761782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of allogeneic NK cells for cancer immunotherapy.
    Geller MA; Miller JS
    Immunotherapy; 2011 Dec; 3(12):1445-59. PubMed ID: 22091681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell responses to viral infection.
    Brandstadter JD; Yang Y
    J Innate Immun; 2011; 3(3):274-9. PubMed ID: 21411975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricking the balance: NK cells in anti-cancer immunity.
    Pahl J; Cerwenka A
    Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
    Lim SA; Kim TJ; Lee JE; Sonn CH; Kim K; Kim J; Choi JG; Choi IK; Yun CO; Kim JH; Yee C; Kumar V; Lee KM
    Cancer Res; 2013 Apr; 73(8):2598-607. PubMed ID: 23580577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells and cancer therapy, what we know and where we are going.
    Ghaemdoust F; Keshavarz-Fathi M; Rezaei N
    Immunotherapy; 2019 Oct; 11(14):1231-1251. PubMed ID: 31422725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells to cure cancer.
    Di Vito C; Mikulak J; Zaghi E; Pesce S; Marcenaro E; Mavilio D
    Semin Immunol; 2019 Feb; 41():101272. PubMed ID: 31085114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H; Qian X
    Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the threshold of natural killer cell responses.
    Narni-Mancinelli E; Ugolini S; Vivier E
    Curr Opin Immunol; 2013 Feb; 25(1):53-8. PubMed ID: 23270590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell-based immunotherapy for cancer.
    Fang F; Xiao W; Tian Z
    Semin Immunol; 2017 Jun; 31():37-54. PubMed ID: 28838796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.
    Arina A; Murillo O; Dubrot J; Azpilikueta A; Alfaro C; Pérez-Gracia JL; Bendandi M; Palencia B; Hervás-Stubbs S; Melero I
    Expert Opin Biol Ther; 2007 May; 7(5):599-615. PubMed ID: 17477799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.